Prevention and management of treatment failure to new oral hepatitis C drugs.
about
Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, FranceHepatitis C virus resistance to the new direct-acting antivirals.Sofosbuvir, velpatasvir and voxilaprevir combination for the treatment of hepatitis C.Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C.Treatment of hepatitis C with new fixed dose combinations.Is HIV still a special population for the treatment of hepatitis C?Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment.Baseline NS5A Resistance Associated Substitutions May Impair DAA Response in Real-World Hepatitis C Patients.Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.Host-targeting therapies for hepatitis C virus infection: current developments and future applications.Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
P2860
Q26700018-761BA47B-4867-4CF7-AA91-6759B41E2836Q38887954-52F426D4-22C2-4414-9A8A-D3183D77477BQ39411801-96D8D904-B6A0-4D67-BFE6-407BB837F870Q40104295-00C4C0F7-C22B-4687-B023-019EB5157D9AQ40148071-A1D5759F-9ED1-44D1-A8BA-9CA82C03F96BQ40609447-D1D2339D-7F5B-4CCF-B6A9-D26DDC6AA368Q41695262-C3D14939-AE94-44CA-87EB-7800CF698918Q41921724-5F0F1E96-3657-44E5-86AE-95A2A4604E58Q47121746-4AA79781-0EF3-4910-8D5A-26EABE2D072AQ49823266-E52BE649-E8E8-4135-89E0-5A9423A5A61FQ55280981-C87C1E9A-0BEB-4920-AB59-A6EF5BBED8B2Q55717379-65417543-08C7-402C-846A-A7A2579593EC
P2860
Prevention and management of treatment failure to new oral hepatitis C drugs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prevention and management of treatment failure to new oral hepatitis C drugs.
@en
type
label
Prevention and management of treatment failure to new oral hepatitis C drugs.
@en
prefLabel
Prevention and management of treatment failure to new oral hepatitis C drugs.
@en
P2093
P2860
P1476
Prevention and management of treatment failure to new oral hepatitis C drugs
@en
P2093
Carmen de Mendoza
José M Peña
José V Fernandez-Montero
Laura Benítez-Gutiérrez
Pablo Barreiro
Pablo Labarga
P2860
P304
P356
10.1080/14656566.2016.1182156
P407
P577
2016-05-09T00:00:00Z